Evidence map›Paper›PMID 42553121›Full record

ArticleFrontiers in endocrinology2026

Factors associated with levothyroxine withdrawal and development of a prediction model in primary hypothyroidism.

Wanli Zheng, Yibei Tang, Xuanyu Chen, Wang Ye, Jingyao Yu, Yihan Sun, Bin Zhang, Guangli Wu, Jipeng Zheng, Yuqing Wang and 3 more

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Wanli ZhengDepartment of General Medicine, People's Hospital of China Medical University (People's Hospital of Liaoning Province), Shenyang, China.
Yibei TangDepartment of General Medicine, People's Hospital of China Medical University (People's Hospital of Liaoning Province), Shenyang, China.
Xuanyu ChenDepartment of General Medicine, People's Hospital of China Medical University (People's Hospital of Liaoning Province), Shenyang, China.
Wang YeDepartment of Emergency, People's Hospital of China Medical University (People's Hospital of Liaoning Province), Shenyang, China.
Jingyao YuDepartment of Emergency, People's Hospital of China Medical University (People's Hospital of Liaoning Province), Shenyang, China.
Yihan SunDepartment of Cardiology, People's Hospital of China Medical University (People's Hospital of Liaoning Province), Shenyang, China.
Bin ZhangDepartment of General Medicine, People's Hospital of China Medical University (People's Hospital of Liaoning Province), Shenyang, China.
Guangli WuDepartment of General Medicine, People's Hospital of China Medical University (People's Hospital of Liaoning Province), Shenyang, China.
Jipeng ZhengDepartment of General Medicine, People's Hospital of China Medical University (People's Hospital of Liaoning Province), Shenyang, China.
Yuqing WangJinzhou Medical University, Jinzhou, China.
Jianchun CuiDepartment of Thyroid and Breast Surgery, People's Hospital of China Medical University (People's Hospital of Liaoning Province), Shenyang, China.
Li LuDepartment of Endocrinology, People's Hospital of China Medical University (People's Hospital of Liaoning Province), Shenyang, China.
Xingai JuDepartment of General Medicine, People's Hospital of China Medical University (People's Hospital of Liaoning Province), Shenyang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To identify factors associated with successful levothyroxine (L-T4) withdrawal in patients with primary hypothyroidism and to develop a clinical prediction model. Methods: We retrospectively included patients with primary hypothyroidism who received L-T4 treatment at our hospital between January 2016 and October 2024 and had a documented withdrawal attempt with follow-up records. Baseline patient data were collected, including sociodemographic characteristics (age, sex, body mass index [BMI], family history of thyroid disease), medication-related indices (L-T4 dosage and treatment duration), clinical classification (subclinical vs. overt hypothyroidism), and laboratory and ultrasound imaging parameters (TSH, FT3, FT4, TPOAb, TgAb, heterogeneous echotexture, and hypoechogenicity). Successful withdrawal was defined as maintenance of euthyroidism for 12 months after stopping L-T4; otherwise, withdrawal was considered unsuccessful. Candidate predictors were screened using univariate logistic regression and entered into multivariable logistic regression to identify independent predictors and construct a nomogram. Discriminative ability was assessed using the area under the receiver operating characteristic curve (AUC). Calibration and internal validation were evaluated using the Hosmer-Lemeshow test and bootstrap resampling (1,000 iterations). Results: A total of 110 patients were included, of whom 39 (35.5%) achieved successful withdrawal and 71 (64.5%) did not. In multivariable analysis, younger age (OR = 0.901, 95% CI: 0.852-0.953, P < 0.001) and subclinical hypothyroidism (OR = 4.879, 95% CI: 1.343-17.723, P = 0.016) were associated with a higher likelihood of successful withdrawal. In contrast, TPOAb positivity (OR = 0.150, 95% CI: 0.040-0.556, P = 0.005) and heterogeneous thyroid echotexture on ultrasound (OR = 0.155, 95% CI: 0.032-0.751, P = 0.021) were associated with a lower likelihood of success. The model showed excellent discrimination (AUC = 0.899, 95% CI: 0.840-0.957, P < 0.001). At the optimal cutoff value of 0.292, sensitivity was 87.2% and specificity was 80.3%. Model fit was good (Hosmer-Lemeshow χ² = 5.448, P = 0.709), and bootstrap validation demonstrated good calibration (mean absolute error = 0.029). Conclusion: Younger age, subclinical hypothyroidism, negative TPOAb, and homogeneous thyroid echotexture were associated with a higher likelihood of successful L-T4 withdrawal. The nomogram model may facilitate pre-withdrawal risk stratification and individualized follow-up planning, supporting quantitative decision-making in clinical practice.

Indexed as

HypothyroidismThyroxineWithholding TreatmentAdultFemaleHumansMaleMiddle AgedNomogramsPrediction AlgorithmsPrognosisRetrospective StudiesThyroxinelevothyroxinenomogramprediction modelprimary hypothyroidismwithdrawal

Identifiers

PMID42553121
PMCPMC13433232

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.